Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

http://www.ci-3.de

The CI3 excellence cluster pools the outstanding expertise in the Rhine-Main cluster region of Germany involving innovative new therapies and diagnostics in the field of individualised immune intervention. To this end, CI3 is putting together a network of players from the business, research and healthcare communities as well as government and is shaping the integral element across the entire innovation and value creation chain. *

	Start	2011-04-14 existent
	Industry	pharmacogenomics/pharmacogenetics
	Person	Türeci, Özlem (Ganymed 200811 CEO + CSO)
	Person 2	Wessel, Rainer (DKFZ 201906– before CI3 Cluster Manager before Ganymed CEO)

	Region	Mainz
	Country	Germany
	Street	17–19 Kupferbergterrasse
	City	55116 Mainz
	Tel	+49-6131-6230581
		Address record changed: 2018-07-24

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Zedira GmbH. (6/25/12). "Press Release: Zedira, Dr. Falk Phama and the University of Mainz Hospital, which Together Comprise a Flagship Project of the CI3 Excellence Cluster, Are to Receive Subsidy Funding for Clinical Development of a Celiac Disease Dru

		Record changed: 2020-01-01

More documents for Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]